Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Paul Franks

Paul Franks

Principal investigator

Paul Franks

Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study

Author

  • Fumiaki Imamura
  • Matthias B. Schulze
  • Stephen J. Sharp
  • Marcela Guevara
  • Dora Romaguera
  • Benedetta Bendinelli
  • Elena Salamanca-Fernández
  • Eva Ardanaz
  • Larraitz Arriola
  • Dagfinn Aune
  • Heiner Boeing
  • Courtney Dow
  • Guy Fagherazzi
  • Paul W. Franks
  • Heinz Freisling
  • Paula Jakszyn
  • Rudolf Kaaks
  • Kay Tee Khaw
  • Tilman Kühn
  • Francesca R. Mancini
  • Giovanna Masala
  • Maria Dolores Chirlaque
  • Peter M. Nilsson
  • Kim Overvad
  • Valeria M. Pala
  • Salvatore Panico
  • Aurora Perez-Cornago
  • Jose R. Quirós
  • Fulvio Ricceri
  • Miguel Rodríguez-Barranco
  • Olov Rolandsson
  • Ivonne Sluijs
  • Magdalena Stepien
  • Annemieke M.W. Spijkerman
  • Anne Tjønneland
  • Tammy Y.N. Tong
  • Rosario Tumino
  • Linda E.T. Vissers
  • Heather A. Ward
  • Claudia Langenberg
  • Elio Riboli
  • Nita G. Forouhi
  • Nick J. Wareham

Summary, in English

Introduction: Beverage consumption is a modifiable risk factor for type 2 diabetes (T2D), but there is insufficient evidence to inform the suitability of substituting 1 type of beverage for another. Objective: The aim of this study was to estimate the risk of T2D when consumption of sugar-sweetened beverages (SSBs) was replaced with consumption of fruit juice, milk, coffee, or tea. Methods: In the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study of 8 European countries (n = 27,662, with 12,333 cases of incident T2D, 1992-2007), beverage consumption was estimated at baseline by dietary questionnaires. Using Prentice-weighted Cox regression adjusting for other beverages and potential confounders, we estimated associations of substituting 1 type of beverage for another on incident T2D. Results: Mean ± SD of estimated consumption of SSB was 55 ± 105 g/d. Means ± SDs for the other beverages were as follows: fruit juice, 59 ± 101 g/d; milk, 209 ± 203 g/d; coffee, 381 ± 372 g/d; and tea, 152 ± 282 g/d. Substituting coffee for SSBs by 250 g/d was associated with a 21% lower incidence of T2D (95% CI: 12%, 29%). The rate difference was-12.0 (95% CI:-20.0,-5.0) per 10,000 person-years among adults consuming SSBs ≥250 g/d (absolute rate = 48.3/10,000). Substituting tea for SSBs was estimated to lower T2D incidence by 22% (95% CI: 15%, 28%) or-11.0 (95% CI:-20.0,-2.6) per 10,000 person-years, whereas substituting fruit juice or milk was estimated not to alter T2D risk significantly. Conclusions: These findings indicate a potential benefit of substituting coffee or tea for SSBs for the primary prevention of T2D and may help formulate public health recommendations on beverage consumption in different populations.

Department/s

  • Genetic and Molecular Epidemiology
  • EpiHealth: Epidemiology for Health
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Internal Medicine - Epidemiology

Publishing year

2019

Language

English

Pages

1985-1993

Publication/Series

Journal of Nutrition

Volume

149

Issue

11

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Endocrinology and Diabetes
  • Nutrition and Dietetics

Keywords

  • beverages
  • diabetes
  • dietary guidelines
  • epidemiology
  • sugar-sweetened beverages

Status

Published

Research group

  • Genetic and Molecular Epidemiology
  • Internal Medicine - Epidemiology

ISBN/ISSN/Other

  • ISSN: 0022-3166